What is the Y-tunnus number of Pharmacon Oy?

Pharmacon Oy is registered with PRH / YTJ under Y-tunnus 3296977-2.

What is the revenue of Pharmacon Oy?

Pharmacon Oy reported revenue of EUR 261K in 2025.

How many employees does Pharmacon Oy have?

Pharmacon Oy employs 1 people as of the latest annual report.

Who is the CEO of Pharmacon Oy?

Mari Heini Marianne Markkula is Deputy auditor of Pharmacon Oy, in role since 2025.

Where is Pharmacon Oy headquartered?

Pharmacon Oy's registered address is Hommaksenkaari 15-E.

Pharmacon Oy

OYActive

Y-tunnus 3296977-2Hommaksenkaari 15-EBusiness and other management consultancy activities · NACE 7020Est. 20221 employees

Revenue 2025

EUR 261K

-1% vs 2024

EBITDA margin

66.1%

-8% vs 2024

Equity ratio

94.9%

Financial strength

Net profit 2025

EUR 138K

-8% vs 2024

EBITDA — year on yearEUR millions

Key figuresAnnual report 2025

Revenue	EUR 261K	-1%
EBITDA	EUR 172K	-8%
Net profit	EUR 138K	-8%
Total assets	EUR 402K	+43%
Equity	EUR 382K	+44%
Employees	1	—

Item	2023	2024	2025
Revenue	187	264	261
Staff expenses	−26	−54	−65
EBITDA	156	188	172
Depreciation & amort.	−0	−0	−0
EBIT	156	188	172
Net financials	−0	−0	0
Profit before tax	156	188	172
Tax	31	38	34
Net profit	125	150	138

Item	2023	2024	2025
Total assets	160	280	402
Equity	125	265	382
Long-term debt	0	0	0
Short-term debt	35	15	21
Total debt	35	15	21

Name	Role	Member since
Current (4)
MH Mari Heini Marianne Markkula Deputy auditor	Deputy auditor	2025
NK Niina Kristiina Uotila Audit	Audit	2025
SA Satu Annikki Rauhala Chief Executive Officer	Chief Executive Officer	2022
MH Marjo Helinä Ollilainen Deputy Member	Deputy Member	2022

Person	Role here	Other companies
Mari Heini Marianne Markkula	Deputy auditor	0 companies
Niina Kristiina Uotila	Audit	0 companies
Satu Annikki Rauhala	Chief Executive Officer	0 companies
Marjo Helinä Ollilainen	Deputy Member	0 companies

Pharmacon Oy

OYActive

Y-tunnus 3296977-2Hommaksenkaari 15-EBusiness and other management consultancy activities · NACE 7020Est. 20221 employees

Revenue 2025

EUR 261K

-1% vs 2024

EBITDA margin

66.1%

-8% vs 2024

Equity ratio

94.9%

Financial strength

Net profit 2025

EUR 138K

-8% vs 2024

EBITDA — year on yearEUR millions

Key figuresAnnual report 2025

Revenue	EUR 261K	-1%
EBITDA	EUR 172K	-8%
Net profit	EUR 138K	-8%
Total assets	EUR 402K	+43%
Equity	EUR 382K	+44%
Employees	1	—